Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integrated Orbital Implants is a private ophthalmic medical device company based in San Diego, California that markets the Bio-eye hydroxyapatite orbital implant for patients who undergo enucleation or evisceration. Its lead commercial product is a porous hydroxyapatite implant derived from natural coral and designed to integrate with orbital tissues, support an ocular prosthesis, and improve prosthetic motility and cosmetic outcomes. The company also offers sterile implant configurations and the P-K Titanium Motility Peg System for selected patients. Its customers are primarily oculoplastic surgeons, ocularists, and optometrists rather than drug-development stakeholders. The business is healthcare-related, but it is not a biotech or therapeutics company; it is a niche commercial medical device manufacturer focused on orbital reconstruction and artificial eye support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integrated Orbital Implants.